MedTrace Logo

A Predictive Score for Arterial Thrombosis Associated With Cancer

NCT05256329 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2022-02-25

No results posted yet for this study

Summary

Cancer is associated with an increased incidence of thrombosis and thromboembolic events are one of the leading causes of morbidity and mortality in this population. The main consideration has been given to venous thromboembolic events (VTEs); arterial thrombotic events (ATEs) have more recently been recognized to precede cancer diagnosis and/or follow it as a serious complication. Thus, while plausible, the relationship between cancer and arterial thrombosis is less well established than for VTE. We sought to undertake the COMPASS-ARTeCAT (Comparison of Methods for thromboembolic risk assessment with clinical Perceptions and AwareneSS in real life patients- Arterial Cancer Associated Thrombosis) study aiming to identify the most clinically relevant clinical predictors of arterial thrombosis in ambulatory patients with specific types of cancer who are going to start or have already started anticancer treatment. This study aims to evaluate the incidence and the association between arterial thromboembolism and occult cancer. Moreover, this study will provide a risk assessment model (RAM) for arterial thrombosis applicable to cancer patients at any time after anticancer therapy initiation

Conditions

Sponsors & Collaborators

  • Institut Universitaire de Cancérologie, Sorbonne University

    collaborator UNKNOWN

  • Third Department of Medicine, Sotiria General Hospital

    collaborator UNKNOWN

  • Oncology Department, Hippokration Hospital

    collaborator UNKNOWN

  • Metaxa Hospital, Cardiology Department, Greece

    collaborator UNKNOWN

  • National and Kapodistrian University of Athens

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-04-01
Completion
2025-12-01

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05256329 on ClinicalTrials.gov